We estimate Pfizer’s valuation to be $32 per share, indicating a solid nearly 40% upside potential. At its current price of $23, Pfizer stock is trading at just 8 times trailing earnings of $2. ...

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.

No Drug Price Pledges by Pfizer, Others in Talks With US Government, Pfizer CEO Says. More. Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022.

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...

Pharmaceutical giant Pfizer has agreed to pay $35 million to settle allegations that it unlawfully hindered the sale of Lipitor, a drug prescribed to lower ...

Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket ...

Pfizer faces significant challenges including patent expiries, drug pricing controls, and questionable management decisions, casting doubt on its future performance.

Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

Trump's so-called “most favored nation” approach to Medicare drug pricing has been controversial since he ... by Medicare and Medicaid because it can set regulations. ... Pfizer, which notched ...

Trump's so-called “most favored nation” approach to Medicare drug pricing has been controversial since he ... by Medicare and Medicaid because it can set regulations. ... Pfizer, which notched ...